Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NOX4 | Q9NPH5 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | RGS12 | O14924 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | LCK | P06239 | 1/20 | 0.55 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.55 |
| ▸ | KDM4C | Q9H3R0 | 5/20 | 0.54 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.45 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.45 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.45 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5961640 | 0.88 | BCL2L1 (0.52) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL156253 | 0.83 | ALDH1A1 (0.60) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL17849006 | 0.80 | KDM4C (0.63) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL12862660 | 0.78 | ALDH1A1 (0.57) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL5720697 | 0.77 | KDM4E (0.54) | ALDH1A1MAPTTDP1PPARAPKM | |
| SCHEMBL346822 | 0.76 | MAPT (0.56) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL29381797 | 0.76 | MAPT (0.56) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL21451256 | 0.76 | ALDH1A1 (0.56) | ALDH1A1MAPTNOX4TDP1RGS12 | |
| SCHEMBL9621441 | 0.75 | KDM4E (0.47) | ALDH1A1MAPTTDP1AKR1C3PKM | |
| SCHEMBL170522 | 0.75 | KDM4C (0.62) | ALDH1A1MAPTTDP1KDM4CCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1221929-B1 | METHOD FOR IMPROVING THE STAY-ON PROPERTIES OF COSMETIC COMPOSITIONS | OREAL (FR) | 2006-09-06 | — | — | EP | claimed |
| US-6730133-B1 | ENZYME IMMOBILIZED IN A SOL-GEL MATRIX; 2-ELECTRON OXIDOREDUCTASES, 4-ELECTRON OXIDOREDUCTASES AND PEROXIDASES; HYDROGEN PEROXIDE; HEAT STABILITY | L'OREAL S.A. (FR) | 2004-05-04 | — | — | US | claimed |
| EP-0627960-B1 | COLLOIDAL AND CONCENTRATED SOLUTION OF MONOCRYSTAL-PARTICLES FROM METALLIC OXIDES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATIONS | RHONE POULENC CHIMIE (FR) | 1996-11-27 | — | — | EP | claimed |
| US-10064792-B2 | Hybrid coated cosmetic powders and methods of making and using same | KOBO PRODUCTS INC. (US) | 2018-09-04 | — | — | US | disclosed |
| US-20080014233-A1 | HYBRID COATED COSMETIC POWDERS AND METHODS OF MAKING AND USING SAME | KOBO PRODUCTS INC. | 2008-01-17 | — | — | US | disclosed |
| WO-2005099651-A1 | HYBRID COATED COSMETIC POWDERS AND METHODS OF MAKING AND USING SAME | KOBO PRODUCTS, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
| US-20040234613-A1 | Hybrid coated cosmetic powders and methods of making and using same | KOBO PRODUCTS, INC. | 2004-11-25 | — | — | US | disclosed |
| US-6730133-B1 | ENZYME IMMOBILIZED IN A SOL-GEL MATRIX; 2-ELECTRON OXIDOREDUCTASES, 4-ELECTRON OXIDOREDUCTASES AND PEROXIDASES; HYDROGEN PEROXIDE; HEAT STABILITY | L'OREAL S.A. (FR) | 2004-05-04 | — | — | US | disclosed |
| US-6352699-B1 | SOL/GEL TYPE COMPOSITION OBTAINED BY MIXING AT LEAST ONE ORGANOMETALLIC COMPOUND, AT LEAST ONE FUNCTIONALIZED ORGANIC POLYMER OR A PRECURSOR OF SAID POLYMER, WATER | L'OREAL (FR) | 2002-03-05 | — | — | US | disclosed |
| US-5556897-A | METAL COMPOUND, ACRYLIC MONOMERS, TRIALKYLBORON | SUN MEDICAL CO., LTD. (JP) | 1996-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040234613-A1 | Hybrid coated cosmetic powders and methods of making and using same | STK11, CLK1, CLK2 | ALDH1A1 4468/4885MAPT 1785/4885NOX4 4608/4885 |
| US-10064792-B2 | Hybrid coated cosmetic powders and methods of making and using same | STK11, CLK1, CLK2 | ALDH1A1 4468/4885MAPT 1785/4885NOX4 4608/4885 |
| US-20080014233-A1 | HYBRID COATED COSMETIC POWDERS AND METHODS OF MAKING AND USING SAME | STK11, CLK1, CLK2 | ALDH1A1 4468/4885MAPT 1785/4885NOX4 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.